Ocugen, Inc. Profile Avatar - Palmy Investing

Ocugen, Inc.

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function…

Biotechnology
US, Malvern [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of OCGN's Analysis
CIK: 1372299 CUSIP: 67577C105 ISIN: US67577C1053 LEI: - UEI: -
Secondary Listings
OCGN has no secondary listings inside our databases.